You just read:

Neovii Announces Publication in Journal of Clinical Oncology Demonstrating Grafalon® Reduces Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation

News provided by

Neovii Pharmaceuticals AG

Oct 24, 2017, 12:52 ET